Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists

https://doi.org/10.1016/j.bmcl.2005.07.052Get rights and content

Abstract

Potent and selective antagonists of the adenosine A2A receptor often contain a nitrogen-rich fused-ring heterocyclic core. Replacement of the core with an isomeric ring system has previously been shown to improve target affinity, selectivity, and in vivo activity. This paper describes the preparation, by a novel route, of A2A receptor antagonists containing the [1,2,4]triazolo[1,5-a]pyrazine nucleus, which is isomeric with the [1,2,4]triazolo[1,5-c]pyrimidine core of a series of known A2A antagonists with in vivo activity in animal models of Parkinson’s disease.

Graphical abstract

This paper describes the preparation, by a novel route, of A2A receptor antagonists containing the [1,2,4]triazolo[1,5-a] pyrazine nucleus, which is isomeric with the [1,2,4]triazolo[1,5-c]pyrimidine core of a series of known A2A antagonists with in vivo activity in animal models of Parkinson’s disease.

  1. Download : Download full-size image

References and notes (22)

  • C.E. Müller

    Drugs Future

    (2000)
    M. Kurokawa et al.

    Br. J. Pharmacol.

    (1994)
  • P.J. Richardson et al.

    TIPS

    (1997)
  • J. Shimada et al.

    Bioorg. Med. Chem. Lett.

    (1997)
    L.J.-S. Knutsen et al.

    Curr. Opin. Inv. Drugs

    (2001)
    T. Kanda et al.

    Ann. Neurol.

    (1998)
    W. Bara-Jimenez et al.

    Neurology

    (2003)
  • B. Cacciari et al.

    Curr. Top. Med. Chem.

    (2003)
  • C.B. Vu et al.

    Bioorg. Med. Chem. Lett.

    (2004)
  • K.A. Jacobson et al.

    J. Med. Chem.

    (1992)
  • B.B. Fredholm et al.

    Pharmacol. Rev.

    (1994)
    V. Ralevic et al.

    Pharmacol. Rev.

    (1998)
    C.E. Müller et al.

    Curr. Pharm. Des.

    (1996)
  • S.-A. Poulsen et al.

    Bioorg. Med. Chem.

    (1998)
  • F. Suzuki et al.
  • J.-F. Chen et al.

    J. Neurosci.

    (2001)
  • Cited by (28)

    View all citing articles on Scopus
    View full text